Global Parp Inhibitor Biomarkers Market Size & Outlook
Global parp inhibitor biomarkers market, 2018-2030 (US$M)
Related Markets
Global parp inhibitor biomarkers market highlights
- The global parp inhibitor biomarkers market generated a revenue of USD 1,060.2 million in 2023 and is expected to reach USD 1,914.0 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 8.8% by 2030.
- In terms of segment, kits accounted for a revenue of USD 692.7 million in 2023.
- Assays is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, UK is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 1,060.2 million |
| Market revenue in 2030 | USD 1,914.0 million |
| Growth rate | 8.8% (CAGR from 2023 to 2030) |
| Largest segment | Kits |
| Fastest growing segment | Assays |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits, Assays |
Other key industry trends
- In terms of revenue, the North America accounted for 37.5% of the global parp inhibitor biomarkers market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, UK is the fastest growing regional market and is projected to reach USD 90.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
PARP Inhibitor Biomarkers Market Scope
PARP Inhibitor Biomarkers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global parp inhibitor biomarkers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to parp inhibitor biomarkers market will help companies and investors design strategic landscapes.
Kits was the largest segment with a revenue share of 65.34% in 2023. Horizon Databook has segmented the Global parp inhibitor biomarkers market based on kits, assays covering the revenue growth of each sub-segment from 2018 to 2030.
- Global PARP Inhibitor Biomarkers Product Outlook (Revenue, USD Million, 2018-2030)
- Kits
- Assays
- Global PARP Inhibitor Biomarkers Services Outlook (Revenue, USD Million, 2018-2030)
- BRCA 1 & 2 Testing
- HRD Testing
- HRR Testing
- Other Services
- Global PARP Inhibitor Biomarkers Application Outlook (Revenue, USD Million, 2018-2030)
- Breast Cancer
- Ovarian Cancer
- Other Application
Reasons to subscribe to Global parp inhibitor biomarkers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global parp inhibitor biomarkers market databook
-
Our clientele includes a mix of parp inhibitor biomarkers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global parp inhibitor biomarkers market, including forecasts for subscribers. This global databook contains high-level insights into Global parp inhibitor biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global parp inhibitor biomarkers market report size, by regions, 2018-2030 (US$M)
Top 10 countries: Parp inhibitor biomarkers market report size, 2023 (US$M)
Global parp inhibitor biomarkers market report share, by product, 2023 & 2030 (%, US$M)
Parp inhibitor biomarkers market: Opportunity assessment by country
Global parp inhibitor biomarkers market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
